SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2023

Schedule of Earnings Per Share, Basic and Diluted

The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)	2023		2022		2023		2022
Net income (loss) available to common shareholders	$	794	$	(148,761)	$	(154,383)	$	(495,761)
Weighted average common shares outstanding - basic	180,649		176,997		179,817		175,935
Effect of dilutive shares:
Restricted stock awards	2,153		—		—		—
Employee stock purchase plan	589		—		—		—
Stock options	646		—		—		—
Performance share units	38		—		—		—
Dilutive potential common shares	3,426		—		—		—
Weighted average common shares outstanding - diluted	184,075		176,997		179,817		175,935
Earnings per common share from net earnings - basic	$	0.00	$	(0.84)	$	(0.86)	$	(2.82)
Earnings per common share from net earnings - diluted	$	0.00	$	(0.84)	$	(0.86)	$	(2.82)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect:


	Three Months Ended September 30,		Nine Months Ended September 30,
(In thousands)	2023	2022	2023	2022
Shares issuable upon conversion of convertible notes	23,231	20,309	23,231	20,309
Shares issuable upon the release of restricted stock awards	—	5,588	6,423	5,588
Shares issuable upon the release of performance share units	—	1,018	1,584	1,018
Shares issuable upon exercise of stock options	—	1,588	1,305	1,588
Shares issuable in connection with acquisitions	—	45	—	45
	23,231	28,548	32,543	28,548